SCIEGEN PHARMACEUTICALS INC

Sciegen Pharmaceuticals Inc. specializes in the manufacturing of sterile and oral pharmaceutical preparations, with demonstrated expertise in the production of active pharmaceutical ingredients and finished dosage forms such as capsules. The company delivers end-to-end pharmaceutical manufacturing services aligned with current Good Manufacturing Practices (cGMP), ensuring compliance with FDA and federal supply chain requirements. Their technical capabilities include formulation development, batch processing, packaging, and distribution of branded and generic therapeutics, with recent work focused on high-demand CNS medications like pregabalin. The firm’s operational rigor supports mission-critical drug supply chains, particularly for controlled substances requiring stringent quality control and traceability. The company has established direct relationships with the Department of Veterans Affairs and the Department of Defense, supplying essential medications to support veteran healthcare and military medical readiness. These engagements reflect a pattern of trusted, recurring procurement for clinically vital, non-novel therapeutics, indicating reliability in meeting urgent and sustained demand for generic pharmaceuticals within federal health systems. Sciegen’s primary focus is in NAICS 325412—pharmaceutical preparation manufacturing—where they operate as a niche contract manufacturer serving federal agencies requiring compliant, scalable production of oral solid dosages. Their market positioning centers on bridging the gap between generic drug development and federal procurement, offering agility in fulfilling specialized formulary needs without reliance on branded product exclusivity. As a small business structured as a 2L entity based in Hauppauge, New York, Sciegen Pharmaceuticals operates with a focused, asset-light manufacturing model. While no federal certifications are currently listed, their consistent award history suggests adherence to federal quality and regulatory standards necessary for DoD and VA contract compliance. The company maintains a targeted geographic footprint aligned with U.S. government pharmaceutical supply chain logistics.